Neurodegenerative Disorders – 18/56

A call for applications to evaluate novel or repurposed interventions for the treatment, management or diagnosis of neurodegenerative conditions, including degenerative dementias. Applications must concentrate on determining the clinical efficacy of interventions. Studies with a strong hypothesisdriven mechanistic component and studies into potentially disease-modifying treatments are likely to be considered a priority under this call. Projects must have a strong collaborative approach, involving at least two of academia, NHS and industry. The EME Programme is particularly keen to encourage collaboration with small and medium enterprises.

The Efficacy and Mechanism Evaluation Programme is accepting stage 1 applications to their commissioned workstream:

In order to apply you will need to carefully review the:

The deadline for applications is 1pm, 21 August 2018


The funder is holding a webinar to support applications to this funding opportunity on – Monday 11 June 2018 11:00am – 12:00pm

To register your interest in attending, please complete the webinar sign-up form.

Supporting information

*Please note: This document is to be used as a guide and to assist with completion of the on-line application form only, for example to see how many characters are accepted in each section and how the printed complete form is laid out. Please do not try to use this as an application form, you must apply using the online form available through the links available when calls are open. You should also refer to the application form guidance notes.

All primary research projects are expected to establish a programme appointed Study Steering Committee and it is important that you read the TSC/SSC Guidance before completing your application. Costs incurred by this committee should be included in the budget as appropriate.

Visit funding web page